Scientists and policymakers debate delaying second vaccine dose
Is it wiser to hold back the second doses everyone will need, or to give as many people as possible a shot now?
There are concerns due to a supply constraint. Only Pfizer and Moderna vaccines are authorized, even though policymakers had hoped for more by now.
Moreover, they are not vaccinating many people as quickly as possible.
— NYT: Top Stories
